secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2023-04-28T23:59:59+00:00
Accession:  0001193125-23-127227
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics announces 1-for-15 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split ratio 1-for-15 effective 12:01 a.m. ET on May 1, 2023; symbol PSTV unchanged.
- Outstanding shares reduced from ~37.4M to ~2.49M; new CUSIP 72941H509.
- Purpose is to raise per-share price above Nasdaq's $1.00 minimum bid requirement.
- No fractional shares issued; cash payment in lieu for fractional interests.
- Equity awards and warrants adjusted proportionately; par value remains $0.001 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312523127227/0001193125-23-127227-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312523127227/d475493d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-127227

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer